Position in ILMN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$65,327,800
-$13,368,200 QoQ
Shares Held
530,000
-11.7% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
4.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Derivatives in ILMN
reported options exposure · as of Dec 31, 2023CallValue
$3,386,187
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Casdin Capital, LLC holds $342,736,102 across 8 Diagnostics & Research names. ILMN ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
|
3,007,164 | $193,120,072 | |
| 2 | ILMN |
Illumina, Inc.
This page
|
530,000 | $65,327,800 | |
| 3 | GH |
Guardant Health, Inc.
|
315,000 | $29,096,550 | |
| 4 | QGEN |
Qiagen N.V.
|
360,000 | $14,414,400 | |
| 5 | GRAL |
GRAIL, Inc.
|
230,000 | $11,886,400 | |
| 6 | PSNL |
Personalis, Inc.
|
1,600,000 | $10,192,000 | |
| 7 | DGX |
Quest Diagnostics Inc
|
50,000 | $9,799,000 | |
| 8 | VCYT |
Veracyte, Inc.
|
276,308 | $8,899,880 |
All Filings in ILMN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,327,800 | 530,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $78,696,000 | 600,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $49,859,250 | 525,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $61,539,450 | 645,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $47,207,300 | 595,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $100,222,500 | 750,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $97,807,500 | 750,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $50,102,400 | 480,000 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $33,127,790 | 248,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,386,187 | 25,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $42,395,067 | 313,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,338,522 | 25,000 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $3,338,522 | 25,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $28,269,411 | 155,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $62,209,400 | 275,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $75,726,651 | 385,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $71,453,459 | 385,000 | Shares | Sole | 2022-11-14 | |
| 2020-09-30 | $9,019,845 | 30,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $10,807,878 | 30,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,970,427 | 30,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||